News >

Dr Waun Ki Hong Reflects on Career Milestones in ASCO 2018 Interview

Gina Columbus @ginacolumbusonc
Published: Friday, Jan 04, 2019

Waun Ki Hong, MD

Waun Ki Hong, MD

Pivotal clinical trials in oncology that laid the groundwork for organ preservation, chemoprevention, and precision medicine can be traced back to pioneering medical oncologist Waun Ki Hong, MD.

during the 2018 ASCO Annual Meeting, Hong reflected on his career milestones in head and neck cancer and how his pioneer initiatives continue to make inroads across malignancies.

OncLive: You were recognized as a 2018 Giant of the Cancer Care® in Head and Neck Cancer. What does this peer-nominated award mean to you?

Hong: This is a wonderful, incredible honor—something I never expected at all. It was a total surprise. I don’t think I belong in the category of the [Giants of Cancer Care®], and when I received an email [about it], I didn’t believe it. It is such a great honor.

You have had a number of notable achievements throughout your career. What stands out to you?

I am a first-generation immigrant of this country. I came to this country in 1970 and, in fact, [this year] is 48 years of my immigration to the United States. I have had a wonderful career and started my medicine training at Veterans Affairs (VA) Medical Center in Boston, and then at Memorial Sloan Kettering Cancer Center, where I did my oncology fellowship. Then, I went back to Boston Veterans Administration Medical Center as chief of medical oncology and then moved to The University of Texas MD Anderson Cancer Center in 1984.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Community Practice Connections™: Immunotherapeutic Strategies with the Potential to Transform Treatment for Genitourinary CancersAug 29, 20191.0
Publication Bottom Border
Border Publication